Stem Cell Manufacturing Market

Stem Cell Manufacturing Market by Product (Consumables, Instrument, HSCs, MSCs, iPSCs, ESCs), Application (Research, Clinical (Autologous, Allogenic), Cell & Tissue Banking), End User (Pharma & Biotech, Hospitals, Tissue Bank) - Global Forecast to 2026

Report Code: BT 6089 May, 2021, by marketsandmarkets.com

[296 Pages Report] The stem cell manufacturing market is projected to reach USD 18.0 billion by 2026 from USD 11.5 billion in 2021, at a CAGR of 9.4% during the forecast period. Growing investments in stem cell-based research, rising awareness about the therapeutic potency of stem cell products, and supportive regulatory framework across developing countries are the key factors supporting the growth of the market.

Stem Cell Manufacturing Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 impact on the global STEM CELL MANUFACTURING market

COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. After the WHO officially declared the outbreak a pandemic, a mix of established pharmaceutical companies and small start-ups stepped forward to develop treatments and vaccines. The bioprocessing industry has experienced transformational changes in terms of operational and personnel management. A majority of the companies developing products for stem cell manufacturing have a better response to staff disruptions and challenges emerging due to COVID-19. This includes non-essential staff working from home, while onsite or essential staff working in shifts with limited movement.

In the case of R&D activities, clinical trials were affected as there were disruptions in the new enrollment of clinical trial participants and keeping the existing patients on therapies. However, researchers have been finding new therapies and treatments to deal with this pandemic. In the last few years, stem cells have been proven to be an effective method to treat pulmonary disorders, including COVID-19. Stem cell therapies derived from MSCs have showcased potential for the treatment of the disease. As a result, there has been an increase in the number of clinical trials on MSCs. Countries such as the US, Spain, the UK, France, Belgium, and Mexico are conducting clinical trials for stem cell therapies to be used in the treatment of COVID-19.

However, Due to nationwide lockdowns, denied wound care services, and canceled or postponed elective surgeries & treatments, the stem cell therapy market declined in 2020. This decline in the stem cell therapy market has negatively impacted the stem cell manufacturing market. Several companies have claimed that their sales decreased due to a restriction in the supply of their products.

Stem cell manufacturing mARKET dynamics

Driver: Growing venture capital investments in stem cell research

Stem cells play an important role in effective disease management as well as specialized research initiatives, such as personalized medicine and genomic testing. Owing to the growing awareness about the therapeutic potency of stem cells and the limited availability of therapeutic treatments for orphan diseases, various public and private stakeholders across the globe are increasingly investing in the development of stem cell-based technologies.

Restraint: Significant operational costs associated with stem cell manufacturing and banking

Stem cell isolation, purification, and storage require specialized techniques (such as expansion, differentiation, cell culture media preparation, and cryopreservation). Moreover, the manufacturing scale-up of stem cell lines and related accessories is often associated with significant technical difficulties that hinder the overall manufacturing process and amount to significant operational costs. Therefore, stem cell products are often priced at a premium as compared to pharmaceutical drugs and biologics.

Opportunity: Supportive regulatory framework across developing countries

Emerging countries (such as South Korea, India, and China) are supporting their respective domestic stem cell industries through various regulatory reforms aimed at aiding the commercialization and research related to stem cell therapy. Supportive regulatory frameworks across developing countries are expected to provide significant growth opportunities to local as well as international players in the stem cell manufacturing market in the next decade.

By product, the consumables segment accounted for the largest share of the stem cell manufacturing market in 2020.

Based on product, the stem cell manufacturing market is segmented into consumables, instruments, and stem cell lines. Consumables dominated the market in 2020. The large share of this segment can be attributed to the frequent purchase of consumables, rising stem cell research, and increasing demand for stem cell therapies.

By application, the research applications segment accounted for the largest share of the stem cell manufacturing market in 2020.

Based on application, the stem cell manufacturing market is categorized into research applications, clinical application, and cell & tissue banking applications. The research application segment dominated the market in 2020 owing to the rising focus on stem cell cytology & pathophysiology research, and growing public-private funding to support stem cell product development and commercialization.

By end-user, the pharmaceutical & biotechnology companies segment accounted for the largest share of the stem cell manufacturing market in 2020.

Based on end-users, the stem cell manufacturing market is segmented into pharmaceutical & biotechnology companies, academic institutes, research laboratories & contract research organizations, hospitals & surgical centers, cell banks & tissue banks, and other end users. The pharmaceutical & biotechnology companies dominated the market in 2020. The large share of this segment can be attributed to the growing emphasis on strategic initiatives (such as acquisitions, partnerships, and collaborations) by pharma and biotech companies to expand their capabilities in stem cell research.

North America accounted for the largest share of the stem cell manufacturing market in 2020.

In 2020, North America accounted for the largest share of the stem cell manufacturing market, followed by Europe. The large share of the North American regional segment can be attributed to the extensive ongoing stem cell research activities, and the availability of public-private funding and grants to support the clinical evaluation of stem cells for various applications.

Stem Cell Manufacturing Market by Region

Key Market Players

Thermo Fisher Scientific (US), Merck Milliopore (Germany), Lonza Group AG (Switzerland), Danaher Corporation (US) and Sartorius AG (Germany) are the prominent players operating in the stem cell manufacturing market.

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market Size Available for Years

2018–2026

Base Year Considered

2020

Forecast Period

2021–2026

Forecast Units

Value (USD Billion)

Segments Covered

Product, Application, End User and Region

Geographies Covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Companies Covered

The major market players include Thermo Fisher Scientific (US), Merck Millipore (Germany), Lonza Group AG (Switzerland), Danaher Corporation (US), Sartorius AG (Germany), Bio-Rad Laboratories (US), Becton, Dickinson and Company (US), Stemcell Technologies (Canada), Fujifilm Holdings Corporation (Japan), Miltenyi Biotec (Germany), Terumo BCT Inc. (US), Corning Inc. (US), Bio-Techne Corporation (US), Takara Bio Group (Japan), Eppendorf AG (Germany), Getinge (Sweden), Himedia Laboratories (India), Anterogen (South Korea), Cellgenix GMBH (Germany) and Promocell (Germany).

The study categorizes the stem cell manufacturing market into the following segments and subsegments:

By Product

  • Consumables
    • Culture Media
    • Other Consumables
  • Instruments
    • Bioreactors and Incubators
    • Cell Sorters
    • Other Instruments
  • Stem Cell Lines
    • Hematopoietic stem cells (HSC)
    • Mesenchymal stem cells (MSC)
    • Induced Pluripotent Stem cells (iPSC)
    • Embryonic stem cells (ESC)
    • Neural Stem cells (NSC)
    • Multipotent adult progenitor stem cells

By Application

  • Research Applications
    • Life science research
    • Drug discovery and development
  • Clinical Application
    • Allogenic stem cell therapy
    • Autologous stem cell therapy
  • Cell & Tissue Banking Applications

By End User

  • Pharmaceutical & Biotechnology Companies
  • Academic institutes, Research laboratories & contract research organizations
  • Hospitals & surgical centres
  • Cell & tissue banks
  • Other End Users

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
  • Middle East and Africa

Recent Developments

  • In January 2021, Thermo Fisher Scientific acquired Henogen S.A., Novasep's viral vector manufacturing business, to strengthen its capabilities for cell and gene vaccines and therapies globally.
  • In November 2020, Lonza Group AG signed an agreement with FUJIFILM Cellular Dynamics. Under the agreement, Lonza granted FUJIFILM Cellular Dynamics expanded use of its non-exclusive license to its innovative Nucleofector technology. Likewise, FUJIFILM Cellular Dynamics granted Lonza a non-exclusive right to use its patents related to iPSC generation. This will accelerate the development and manufacture of cell therapies.
  • In March 2020, Danaher acquired the Biopharma business from General Electric Company’s Life Sciences division and renamed it Cytiva.
  • In October 2019, Thermo Fisher Scientific launched Gibco BenchStable Media, which remains stable at room temperature and reduces reliance on cold storage.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 41)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE
           FIGURE 1 STEM CELL MANUFACTURING MARKET SEGMENTATION
           1.3.1 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 45)
    2.1 RESEARCH DATA
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                    FIGURE 2 PRIMARY SOURCES
                    FIGURE 3 STEM CELL MANUFACTURING MARKET: BREAKDOWN OF PRIMARIES
    2.2 MARKET SIZE ESTIMATION
           FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 – REVENUE SHARE ANALYSIS, 2020
           FIGURE 5 AVERAGE MARKET SIZE ESTIMATION, 2020
           FIGURE 6 STEM CELL MANUFACTURING MARKET: CAGR PROJECTIONS, 2021–2026
           FIGURE 7 STEM CELL MANUFACTURING MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
           FIGURE 8 DATA TRIANGULATION METHODOLOGY
    2.4 RESEARCH ASSUMPTIONS
    2.5 RISK ANALYSIS

3 EXECUTIVE SUMMARY (Page No. - 55)
    FIGURE 9 STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
    FIGURE 10 STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    FIGURE 11 STEM CELL MANUFACTURING MARKET, BY END USER 2021 VS. 2026 (USD MILLION)
    FIGURE 12 GEOGRAPHICAL SNAPSHOT: STEM CELL MANUFACTURING MARKET

4 PREMIUM INSIGHTS (Page No. - 58)
    4.1 STEM CELL MANUFACTURING MARKET OVERVIEW
           FIGURE 13 GROWING INVESTMENTS IN STEM CELL-BASED RESEARCH TO DRIVE MARKET GROWTH
    4.2 NORTH AMERICA: STEM CELL MANUFACTURING MARKET SHARE, BY PRODUCT & COUNTRY (2020)
           FIGURE 14 CONSUMABLES ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN STEM CELL MANUFACTURING MARKET IN 2020
    4.3 STEM CELL MANUFACTURING MARKET SHARE, BY END USER, 2020
           FIGURE 15 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2020
    4.4 STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
           FIGURE 16 RESEARCH APPLICATIONS WILL CONTINUE TO DOMINATE THE APPLICATIONS MARKET
    4.5 STEM CELL MANUFACTURING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
           FIGURE 17 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH IN THE STEM CELL MANUFACTURING MARKET FROM 2021 TO 2026

5 MARKET OVERVIEW (Page No. - 62)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           TABLE 1 STEM CELL MANUFACTURING MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Growing venture capital investments in stem cell research
                    5.2.1.2 Increasing awareness about the therapeutic potency of stem cell products
                    5.2.1.3 Technological advancements in stem cell manufacturing
                    5.2.1.4 Increasing incidence of cancer and collaborative efforts in cancer research
                               TABLE 2 GLOBAL CANCER INCIDENCE, 2020 VS. 2040
           5.2.2 RESTRAINTS
                    5.2.2.1 Significant operational costs associated with stem cell manufacturing and banking
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Supportive regulatory framework across developing countries
                    5.2.3.2 Government initiatives to boost the biotechnology and biopharmaceutical industries
                    5.2.3.3 Increased market focus on mesenchymal stem cells and induced pluripotent stem cells
           5.2.4 CHALLENGES
                    5.2.4.1 Technical limitations associated with manufacturing scale-up
                    5.2.4.2 Socio-ethical concerns related to the use of allogeneic and human embryonic stem cells
    5.3 IMPACT OF THE COVID-19 PANDEMIC ON THE STEM CELL MANUFACTURING MARKET
           5.3.1 INTRODUCTION
           5.3.2 SUPPLY CHAIN
           5.3.3 RESEARCH & DEVELOPMENT
                    FIGURE 18 CLINICAL TRIALS FOR COVID-19 USING STEM CELLS, BY REGION
           5.3.4 RESEARCH FUNDING
    5.4 PORTER’S FIVE FORCES ANALYSIS
           TABLE 3 STEM CELL MANUFACTURING MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.4.1 THREAT OF NEW ENTRANTS
           5.4.2 THREAT OF SUBSTITUTES
           5.4.3 BARGAINING POWER OF SUPPLIERS
           5.4.4 BARGAINING POWER OF BUYERS
           5.4.5 DEGREE OF COMPETITION
    5.5 VALUE CHAIN ANALYSIS 
           FIGURE 19 VALUE CHAIN ANALYSIS OF THE STEM CELL MANUFACTURING MARKET: RAW MATERIAL, MANUFACTURING, & ASSEMBLY PHASES ADD MAXIMUM VALUE
    5.6 SUPPLY CHAIN ANALYSIS
                    FIGURE 20 STEM CELL MANUFACTURING MARKET: SUPPLY CHAIN ANALYSIS
    5.7 TECHNOLOGY ANALYSIS
           5.7.1 BIOREACTORS
                    TABLE 4 SINGLE-USE BIOREACTORS VS. STAINLESS-STEEL BIOREACTORS
           5.7.2 CELL CULTURE MEDIA
           5.7.3 CELL IMAGING SYSTEMS
    5.8 ECOSYSTEM ANALYSIS
                    FIGURE 21 ECOSYSTEM ANALYSIS: STEM CELL MANUFACTURING MARKET
                    TABLE 5 ECOSYSTEM ANALYSIS
    5.9 PATENT ANALYSIS
                    FIGURE 22 PATENT APPLICATIONS FOR STEM CELL MANUFACTURING, JANUARY 2010–DECEMBER 2020
    5.10 PRICING ANALYSIS
                    TABLE 6 AVERAGE SELLING PRICE OF LAB-SCALE SINGLE-USE BIOREACTORS, BY REGION (2020)
                    TABLE 7 AVERAGE SELLING PRICE OF STEM CELL LINES (USD), BY REGION (2020)
    5.11 REGULATORY ANALYSIS
           5.11.1 REGULATORY ANALYSIS FOR STEM CELL MANUFACTURING PRODUCTS
                    5.11.1.1 North America
                               5.11.1.1.1 US
                    TABLE 8 US FDA: MEDICAL DEVICE CLASSIFICATION
                    TABLE 9 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
                               5.11.1.1.2 Canada
                    5.11.1.2 Europe
           5.11.2 REGULATORY ANALYSIS FOR STEM CELL THERAPY PRODUCTS
                    5.11.2.1 US
                    5.11.2.2 European Union

6 STEM CELL MANUFACTURING MARKET, BY PRODUCT (Page No. - 82)
    6.1 INTRODUCTION
           TABLE 10 STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
    6.2 CONSUMABLES
           TABLE 11 STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 12 STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY REGION, 2019–2026 (USD MILLION)
           TABLE 13 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 14 EUROPE: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 15 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY COUNTRY, 2019–2026 (USD MILLION)
           6.2.1 CULTURE MEDIA
                    6.2.1.1 Rising stem cell research and increasing demand for stem cell therapies will contribute to the adoption of culture media
                               TABLE 16 STEM CELL MANUFACTURING MARKET FOR CULTURE MEDIA, BY REGION, 2019–2026 (USD MILLION)
                               TABLE 17 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CULTURE MEDIA, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 18 EUROPE: STEM CELL MANUFACTURING MARKET FOR CULTURE MEDIA, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 19 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CULTURE MEDIA, BY COUNTRY, 2019–2026 (USD MILLION)
           6.2.2 OTHER CONSUMABLES
                    TABLE 20 STEM CELL MANUFACTURING MARKET FOR OTHER CONSUMABLES, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 21 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 22 EUROPE: STEM CELL MANUFACTURING MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 23 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2019–2026 (USD MILLION)
    6.3 INSTRUMENTS
           TABLE 24 STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 25 STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY REGION, 2019–2026 (USD MILLION)
           TABLE 26 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 27 EUROPE: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 28 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY COUNTRY, 2019–2026 (USD MILLION)
           6.3.1 BIOREACTORS & INCUBATORS
                    6.3.1.1 The introduction of advanced bioreactors and incubators is contributing to market growth
                               TABLE 29 STEM CELL MANUFACTURING MARKET FOR BIOREACTORS & INCUBATORS, BY REGION, 2019–2026 (USD MILLION)
                               TABLE 30 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR BIOREACTORS & INCUBATORS, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 31 EUROPE: STEM CELL MANUFACTURING MARKET FOR BIOREACTORS & INCUBATORS, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 32 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR BIOREACTORS & INCUBATORS, BY COUNTRY, 2019–2026 (USD MILLION)
           6.3.2 CELL SORTERS
                    6.3.2.1 Growth can be attributed to the development of novel cell sorting technologies such as microfluidics
                               TABLE 33 STEM CELL MANUFACTURING MARKET FOR CELL SORTERS, BY REGION, 2019–2026 (USD MILLION)
                               TABLE 34 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CELL SORTERS, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 35 EUROPE: STEM CELL MANUFACTURING MARKET FOR CELL SORTERS, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 36 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CELL SORTERS, BY COUNTRY, 2019–2026 (USD MILLION)
           6.3.3 OTHER INSTRUMENTS
                    TABLE 37 STEM CELL MANUFACTURING MARKET FOR OTHER INSTRUMENTS, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 38 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 39 EUROPE: STEM CELL MANUFACTURING MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 40 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2019–2026 (USD MILLION)
    6.4 STEM CELL LINES
           TABLE 41 STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 42 STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY REGION, 2019–2026 (USD MILLION)
           TABLE 43 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 44 EUROPE: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 45 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY COUNTRY, 2019–2026 (USD MILLION)
           6.4.1 HEMATOPOIETIC STEM CELLS
                    6.4.1.1 Growth is driven by the increasing adoption of cord blood banking
                               TABLE 46 HEMATOPOIETIC STEM CELLS MARKET, BY REGION, 2019–2026 (USD MILLION)
                               TABLE 47 NORTH AMERICA: HEMATOPOIETIC STEM CELLS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 48 EUROPE: HEMATOPOIETIC STEM CELLS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 49 ASIA PACIFIC: HEMATOPOIETIC STEM CELLS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.4.2 MESENCHYMAL STEM CELLS
                    6.4.2.1 Ease of cell harvesting, processing, and preservation drives the adoption of MSCs
                               TABLE 50 MESENCHYMAL STEM CELLS MARKET, BY REGION, 2019–2026 (USD MILLION)
                               TABLE 51 NORTH AMERICA: MESENCHYMAL STEM CELLS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 52 EUROPE: MESENCHYMAL STEM CELLS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 53 ASIA PACIFIC: MESENCHYMAL STEM CELLS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.4.3 INDUCED PLURIPOTENT STEM CELLS
                    6.4.3.1 Growth can be attributed to the increased adoption of iPSCs in research on cell therapies & regenerative medicine
                               TABLE 54 INDUCED PLURIPOTENT STEM CELLS MARKET, BY REGION, 2019–2026 (USD MILLION)
                               TABLE 55 NORTH AMERICA: INDUCED PLURIPOTENT STEM CELLS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 56 EUROPE: INDUCED PLURIPOTENT STEM CELLS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 57 ASIA PACIFIC: INDUCED PLURIPOTENT STEM CELLS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.4.4 EMBRYONIC STEM CELLS
                    6.4.4.1 Rising research activity in cancer precision medicine contributes to segmental growth
                               TABLE 58 EMBRYONIC STEM CELLS MARKET, BY REGION, 2019–2026 (USD MILLION)
                               TABLE 59 NORTH AMERICA: EMBRYONIC STEM CELLS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 60 EUROPE: EMBRYONIC STEM CELLS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 61 ASIA PACIFIC: EMBRYONIC STEM CELLS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.4.5 NEURAL STEM CELLS
                    6.4.5.1 The introduction of novel isolation and expansion techniques for NSCs will drive the market
                               TABLE 62 NEURAL STEM CELLS MARKET, BY REGION, 2019–2026 (USD MILLION)
                               TABLE 63 NORTH AMERICA: NEURAL STEM CELLS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 64 EUROPE: NEURAL STEM CELLS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 65 ASIA PACIFIC: NEURAL STEM CELLS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.4.6 MULTIPOTENT ADULT PROGENITOR STEM CELLS
                    6.4.6.1 Rising awareness of the role of MAPCs in research
                               TABLE 66 MULTIPOTENT ADULT PROGENITOR STEM CELLS MARKET, BY REGION, 2019–2026 (USD MILLION)
                               TABLE 67 NORTH AMERICA: MULTIPOTENT ADULT PROGENITOR STEM CELLS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 68 EUROPE: MULTIPOTENT ADULT PROGENITOR STEM CELLS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 69 ASIA PACIFIC: MULTIPOTENT ADULT PROGENITOR STEM CELLS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)

7 STEM CELL MANUFACTURING MARKET, BY APPLICATION (Page No. - 111)
    7.1 INTRODUCTION
           TABLE 70 STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
    7.2 RESEARCH APPLICATIONS
           TABLE 71 STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 72 STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
           TABLE 73 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 74 EUROPE: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 75 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
           7.2.1 LIFE SCIENCE RESEARCH
                    7.2.1.1 Market growth is driven by the increasing research focus on stem cell cytology & pathology
                               TABLE 76 STEM CELL MANUFACTURING MARKET FOR LIFE SCIENCE RESEARCH, BY REGION, 2019–2026 (USD MILLION)
                               TABLE 77 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 78 EUROPE: STEM CELL MANUFACTURING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 79 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2019–2026 (USD MILLION)
           7.2.2 DRUG DISCOVERY & DEVELOPMENT
                    7.2.2.1 Increasing research expenditure by pharma and biotech companies will contribute to market growth
                               TABLE 80 STEM CELL MANUFACTURING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2019–2026 (USD MILLION)
                               TABLE 81 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 82 EUROPE: STEM CELL MANUFACTURING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 83 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION)
    7.3 CLINICAL APPLICATIONS
           TABLE 84 STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 85 STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
           TABLE 86 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 87 EUROPE: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 88 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
           7.3.1 ALLOGENEIC STEM CELL THERAPY
                    7.3.1.1 Wide therapeutic applications of stem cell lines to drive growth
                               TABLE 89 STEM CELL MANUFACTURING MARKET FOR ALLOGENEIC STEM CELL THERAPY, BY REGION, 2019–2026 (USD MILLION)
                               TABLE 90 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR ALLOGENEIC STEM CELL THERAPY, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 91 EUROPE: STEM CELL MANUFACTURING MARKET FOR ALLOGENEIC STEM CELL THERAPY, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 92 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR ALLOGENEIC STEM CELL THERAPY, BY COUNTRY, 2019–2026 (USD MILLION)
           7.3.2 AUTOLOGOUS STEM CELL THERAPY
                    7.3.2.1 Increasing patient preference for autologous stem cell therapy will drive segmental growth
                               TABLE 93 STEM CELL MANUFACTURING MARKET FOR AUTOLOGOUS STEM CELL THERAPY, BY REGION, 2019–2026 (USD MILLION)
                               TABLE 94 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR AUTOLOGOUS STEM CELL THERAPY, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 95 EUROPE: STEM CELL MANUFACTURING MARKET FOR AUTOLOGOUS STEM CELL THERAPY, BY COUNTRY, 2019–2026 (USD MILLION)
                               TABLE 96 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR AUTOLOGOUS STEM CELL THERAPY, BY COUNTRY, 2019–2026 (USD MILLION)
    7.4 CELL & TISSUE BANKING APPLICATIONS
           7.4.1 RISING DEMAND FOR CORD BLOOD STEM CELL BANKING INDICATES FAVORABLE PROSPECTS
                    TABLE 97 STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKING APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 98 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKING APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 99 EUROPE: STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKING APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 100 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKING APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)

8 STEM CELL MANUFACTURING MARKET, BY END USER (Page No. - 127)
    8.1 INTRODUCTION
           TABLE 101 STEM CELL MANUFACTURING MARKET, BY END USER, 2019–2026 (USD MILLION)
    8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
           8.2.1 GROWTH IS DRIVEN BY INCREASING PRIVATE INVESTMENTS FOR STEM CELL-BASED RESEARCH
                    TABLE 102 STEM CELL MANUFACTURING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 103 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 104 EUROPE: STEM CELL MANUFACTURING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 105 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
    8.3 ACADEMIC INSTITUTES, RESEARCH LABORATORIES, AND CONTRACT RESEARCH ORGANIZATIONS
           8.3.1 MARKET GROWTH IS DRIVEN BY INCREASED PUBLIC FUNDING FOR RESEARCH ACTIVITIES
                    TABLE 106 STEM CELL MANUFACTURING MARKET FOR ACADEMIC INSTITUTES, RESEARCH LABORATORIES, AND CROS, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 107 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR ACADEMIC INSTITUTES, RESEARCH LABORATORIES, AND CROS, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 108 EUROPE: STEM CELL MANUFACTURING MARKET FOR ACADEMIC INSTITUTES, RESEARCH LABORATORIES, AND CROS, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 109 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR ACADEMIC INSTITUTES, RESEARCH LABORATORIES, AND CROS, BY COUNTRY, 2019–2026 (USD MILLION)
    8.4 HOSPITALS & SURGICAL CENTERS
           8.4.1 GROWTH CAN BE ATTRIBUTED TO IMPROVED HEALTHCARE INFRASTRUCTURE
                    TABLE 110 STEM CELL MANUFACTURING MARKET FOR HOSPITALS & SURGICAL CENTERS, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 111 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR HOSPITALS & SURGICAL CENTERS, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 112 EUROPE: STEM CELL MANUFACTURING MARKET FOR HOSPITALS & SURGICAL CENTERS, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 113 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR HOSPITALS & SURGICAL CENTERS, BY COUNTRY, 2019–2026 (USD MILLION)
    8.5 CELL & TISSUE BANKS
           8.5.1 GROWING APPLICATION OF STEM CELLS IN DISEASE TREATMENT WILL DRIVE MARKET GROWTH
                    TABLE 114 STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKS, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 115 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKS, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 116 EUROPE: STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKS, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 117 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKS, BY COUNTRY, 2019–2026 (USD MILLION)
    8.6 OTHER END USERS
            TABLE 118 STEM CELL MANUFACTURING MARKET FOR OTHER END USERS, BY REGION, 2019–2026 (USD MILLION)
            TABLE 119 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)
            TABLE 120 EUROPE: STEM CELL MANUFACTURING MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)
            TABLE 121 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)

9 STEM CELL MANUFACTURING MARKET, BY REGION (Page No. - 139)
    9.1 INTRODUCTION
           TABLE 122 STEM CELL MANUFACTURING MARKET, BY REGION, 2019–2026 (USD MILLION)
    9.2 NORTH AMERICA
           FIGURE 23 NORTH AMERICA: STEM CELL MANUFACTURING MARKET SNAPSHOT
           TABLE 123 NORTH AMERICA: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 124 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 125 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 126 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 127 NORTH AMERICA: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
           TABLE 128 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 129 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 130 NORTH AMERICA: STEM CELL MANUFACTURING MARKET, BY END USER, 2019–2026 (USD MILLION)
           TABLE 131 NORTH AMERICA: STEM CELL MANUFACTURING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           9.2.1 US
                    9.2.1.1 Continued focus to strengthen R&D to drive the market in the US
                               TABLE 132 US: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 133 US: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 134 US: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 135 US: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 136 US: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                               TABLE 137 US: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 138 US: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 139 US: STEM CELL MANUFACTURING MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.2.2 CANADA
                    9.2.2.1 Rising government investment to drive the market in Canada
                               TABLE 140 CANADA: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 141 CANADA: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 142 CANADA: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 143 CANADA: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 144 CANADA: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                               TABLE 145 CANADA: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 146 CANADA: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 147 CANADA: STEM CELL MANUFACTURING MARKET, BY END USER, 2019–2026 (USD MILLION)
    9.3 EUROPE
           TABLE 148 EUROPE: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 149 EUROPE: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 150 EUROPE: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 151 EUROPE: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 152 EUROPE: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
           TABLE 153 EUROPE: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 154 EUROPE: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 155 EUROPE: STEM CELL MANUFACTURING MARKET, BY END USER, 2019–2026 (USD MILLION)
           TABLE 156 EUROPE: STEM CELL MANUFACTURING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           9.3.1 GERMANY
                    9.3.1.1 Strong growth in the biotechnology industry to drive market growth in the country
                               TABLE 157 GERMANY: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 158 GERMANY: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 159 GERMANY: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 160 GERMANY: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 161 GERMANY: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                               TABLE 162 GERMANY: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 163 GERMANY: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 164 GERMANY: STEM CELL MANUFACTURING MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.2 FRANCE
                    9.3.2.1 Government support in stem cell manufacturing to drive the market
                               TABLE 165 FRANCE: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 166 FRANCE: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 167 FRANCE: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 168 FRANCE: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 169 FRANCE: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                               TABLE 170 FRANCE: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 171 FRANCE: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 172 FRANCE: STEM CELL MANUFACTURING MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.3 UK
                    9.3.3.1 Focus on innovation will increase demand for stem-cell-based therapeutics
                               TABLE 173 UK: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 174 UK: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 175 UK: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 176 UK: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 177 UK: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                               TABLE 178 UK: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 179 UK: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 180 UK: STEM CELL MANUFACTURING MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.4 ITALY
                    9.3.4.1 Initiatives encouraging the development of cell and gene therapy to boost the demand for stem cell manufacturing in the country
                               TABLE 181 ITALY: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 182 ITALY: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 183 ITALY: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 184 ITALY: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 185 ITALY: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                               TABLE 186 ITALY: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 187 ITALY: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
"                   TABLE 188 ITALY: STEM CELL MANUFACTURING MARKET, BY END USER, 2019–2026 (USD MILLION) "
           9.3.5 SPAIN
                    9.3.5.1 Increasing funding from private and public organizations to drive the growth of the market in Spain
                               TABLE 189 SPAIN: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 190 SPAIN: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 191 SPAIN: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 192 SPAIN: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 193 SPAIN: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                               TABLE 194 SPAIN: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 195 SPAIN: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 196 SPAIN: STEM CELL MANUFACTURING MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.6 ROE
                    TABLE 197 ROE: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                    TABLE 198 ROE: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 199 ROE: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 200 ROE: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 201 ROE: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    TABLE 202 ROE: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 203 ROE: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 204 ROE: STEM CELL MANUFACTURING MARKET, BY END USER, 2019–2026 (USD MILLION)
    9.4 ASIA PACIFIC
           FIGURE 24 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET SNAPSHOT
           TABLE 205 APAC: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 206 APAC: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 207 APAC: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 208 APAC: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 209 APAC: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
           TABLE 210 APAC: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 211 APAC: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 212 APAC: STEM CELL MANUFACTURING MARKET, BY END USER, 2019–2026 (USD MILLION)
           TABLE 213 APAC: STEM CELL MANUFACTURING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           9.4.1 CHINA
                    9.4.1.1 Increasing clinical trials for stem cells and innovations to drive the market
                               TABLE 214 CHINA: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 215 CHINA: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 216 CHINA: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 217 CHINA: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 218 CHINA: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                               TABLE 219 CHINA: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 220 CHINA: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 221 CHINA: STEM CELL MANUFACTURING MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.4.2 JAPAN
                    9.4.2.1 Growing collaborations for stem cell research to drive the growth of the market in the country
                               TABLE 222 JAPAN: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 223 JAPAN: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 224 JAPAN: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 225 JAPAN: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 226 JAPAN: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                               TABLE 227 JAPAN: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 228 JAPAN: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 229 JAPAN: STEM CELL MANUFACTURING MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.4.3 INDIA
                    9.4.3.1 The growing prevalence of chronic diseases and focus on stem cell research would drive demand in the country
                               TABLE 230 INDIA: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 231 INDIA: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 232 INDIA: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 233 INDIA: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 234 INDIA: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                               TABLE 235 INDIA: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 236 INDIA: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 237 INDIA: STEM CELL MANUFACTURING MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.4.4 REST OF ASIA PACIFIC
                    TABLE 238 ROAPAC: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                    TABLE 239 ROAPAC: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 240 ROAPAC: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 241 ROAPAC: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 242 ROAPAC: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    TABLE 243 ROAPAC: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 244 ROAPAC: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 245 ROAPAC: STEM CELL MANUFACTURING MARKET, BY END USER, 2019–2026 (USD MILLION)
    9.5 LATIN AMERICA
           9.5.1 GROWING PHARMACEUTICAL INDUSTRY IN THE REGION PROJECTED TO DRIVE THE MARKET GROWTH
                    TABLE 246 LATIN AMERICA: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                    TABLE 247 LATIN AMERICA: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 248 LATIN AMERICA: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 249 LATIN AMERICA: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 250 LATIN AMERICA: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    TABLE 251 LATIN AMERICA: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 252 LATIN AMERICA: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 253 LATIN AMERICA: STEM CELL MANUFACTURING MARKET, BY END USER, 2019–2026 (USD MILLION)
    9.6 MIDDLE EAST & AFRICA
           9.6.1 INCREASING FUNDING AND COLLABORATIONS TO DRIVE MARKET GROWTH IN THE REGION
                    TABLE 254 MEA: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                    TABLE 255 MEA: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 256 MEA: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 257 MEA: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 258 MEA: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    TABLE 259 MEA: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 260 MEA: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 261 MEA: STEM CELL MANUFACTURING MARKET, BY END USER, 2019–2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. - 201)
     10.1 OVERVIEW
     10.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN
             FIGURE 25 KEY PLAYER STRATEGIES IN THE STEM CELL MANUFACTURING MARKET, 2018– 2021
     10.3 MARKET SHARE ANALYSIS
             FIGURE 26 STEM CELL MANUFACTURING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
     10.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
     10.5 COMPANY EVALUATION QUADRANT
             10.5.1 STARS
             10.5.2 EMERGING LEADERS
             10.5.3 PERVASIVE PLAYERS
             10.5.4 EMERGING COMPANIES
                        FIGURE 28 STEM CELL MANUFACTURING MARKET: COMPANY EVALUATION QUADRANT, 2020
     10.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES
             10.6.1 PROGRESSIVE COMPANIES
             10.6.2 STARTING BLOCKS
             10.6.3 RESPONSIVE COMPANIES
             10.6.4 DYNAMIC COMPANIES
                    FIGURE 29 STEM CELL MANUFACTURING MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2020
     10.7 PRODUCT FOOTPRINT OF COMPANIES
             TABLE 262 PRODUCT PORTFOLIO ANALYSIS: STEM CELL MANUFACTURING MARKET (2020)
     10.8 GEOGRAPHIC FOOTPRINT OF COMPANIES
             TABLE 263 GEOGRAPHIC FOOTPRINT: STEM CELL MANUFACTURING MARKET (2020)
     10.9 MARKET EVALUATION FRAMEWORK 
            TABLE 264 MARKET EVALUATION FRAMEWORK: PARTNERSHIPS, AGREEMENTS, JOINT VENTURES, AND COLLABORATIONS—THE MAJOR STRATEGIES ADOPTED BY PLAYERS
     10.10 COMPETITIVE SCENARIO
             10.10.1 STEM CELL MANUFACTURING MARKET: PRODUCT LAUNCHES, JANUARY 2018–APRIL 2021
             10.10.2 STEM CELL MANUFACTURING MARKET: DEALS, JANUARY 2018–APRIL 2021
             10.10.3 STEM CELL MANUFACTURING MARKET: EXPANSIONS, JANUARY 2018–

11 COMPANY PROFILES (Page No. - 213)
     11.1 KEY MARKET PLAYERS
(Introduction, Products offered, Recent developments, SWOT analysis, MNM view)* 
             11.1.1 THERMO FISHER SCIENTIFIC
                        TABLE 265 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
                        FIGURE 30 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020)
                        TABLE 266 THERMO FISHER SCIENTIFIC: PRODUCTS OFFERED
             11.1.2 MERCK MILLIPORE
                        TABLE 267 MERCK MILLIPORE: BUSINESS OVERVIEW
                        FIGURE 31 MERCK MILLIPORE: COMPANY SNAPSHOT (2020)
                        TABLE 268 MERCK MILLIPORE: PRODUCTS OFFERED
             11.1.3 LONZA GROUP
                        TABLE 269 LONZA GROUP: BUSINESS OVERVIEW
                        FIGURE 32 LONZA GROUP AG: COMPANY SNAPSHOT (2020)
                        TABLE 270 LONZA GROUP: PRODUCTS OFFERED
             11.1.4 DANAHER CORPORATION
                        TABLE 271 DANAHER CORPORATION: BUSINESS OVERVIEW
                        FIGURE 33 DANAHER CORPORATION: COMPANY SNAPSHOT (2020)
                        TABLE 272 DANAHER CORPORATION: PRODUCTS OFFERED
             11.1.5 SARTORIUS AG
                        TABLE 273 SARTORIUS AG: BUSINESS OVERVIEW
                        FIGURE 34 SARTORIUS AG: COMPANY SNAPSHOT (2020)
                        TABLE 274 SARTORIUS AG: PRODUCTS OFFERED
             11.1.6 BECTON, DICKINSON AND COMPANY
                        TABLE 275 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
                        FIGURE 35 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
                        TABLE 276 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
             11.1.7 EPPENDORF AG
                        TABLE 277 EPPENDORF AG: BUSINESS OVERVIEW
                        FIGURE 36 EPPENDORF AG: COMPANY SNAPSHOT (2019)
                        TABLE 278 EPPENDORF AG: PRODUCTS OFFERED
             11.1.8 CORNING INC.
                        TABLE 279 CORNING INC.: BUSINESS OVERVIEW
                        FIGURE 37 CORNING INC.: COMPANY SNAPSHOT (2020)
                        TABLE 280 CORNING INC.: PRODUCTS OFFERED
             11.1.9 BIO-RAD LABORATORIES
                        TABLE 281 BIO-RAD LABORATORIES: BUSINESS OVERVIEW
                        FIGURE 38 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2020)
                        TABLE 282 BIO-RAD LABORATORIES: PRODUCTS OFFERED
             11.1.10 TAKARA BIO GROUP
                        TABLE 283 TAKARA BIO GROUP: BUSINESS OVERVIEW
                        FIGURE 39 TAKARA BIO GROUP: COMPANY SNAPSHOT (2020)
                        TABLE 284 TAKARA BIO GROUP: PRODUCTS OFFERED
             11.1.11 FUJIFILM HOLDINGS CORPORATION
                        TABLE 285 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW
                        FIGURE 40 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2020)
                        TABLE 286 FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED
             11.1.12 GETINGE AB
                        TABLE 287 GETINGE AB: BUSINESS OVERVIEW
                        FIGURE 41 GETINGE AB: COMPANY SNAPSHOT (2020)
                        TABLE 288 GETINGE AB: PRODUCTS OFFERED
             11.1.13 TERUMO CORPORATION
                        TABLE 289 TERUMO CORPORATION: BUSINESS OVERVIEW
                        FIGURE 42 TERUMO CORPORATION: COMPANY SNAPSHOT (2020)
                        TABLE 290 TERUMO CORPORATION: PRODUCTS OFFERED
             11.1.14 BIO-TECHNE CORPORATION
                        TABLE 291 BIO-TECHNE CORPORATION: BUSINESS OVERVIEW
                        FIGURE 43 BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2020)
                        TABLE 292 BIO-TECHNE CORPORATION: PRODUCTS OFFERED
             11.1.15 HIMEDIA LABORATORIES
                        TABLE 293 HIMEDIA LABORATORIES: BUSINESS OVERVIEW
                        TABLE 294 HIMEDIA LABORATORIES: PRODUCTS OFFERED
     11.2 OTHER PLAYERS 
             11.2.1 STEMCELL TECHNOLOGIES INC.
                        TABLE 295 STEMCELL TECHNOLOGIES: BUSINESS OVERVIEW 
                        TABLE 296 STEMCELL TECHNOLOGIES: PRODUCTS OFFERED 
             11.2.2 MILTENYI BIOTEC GMBH 
                        TABLE 297 MILTENYI BIOTEC GMBH: BUSINESS OVERVIEW 
                        TABLE 298 MILTENYI BIOTEC GMBH: PRODUCTS OFFERED 
             11.2.3 PROMOCELL 
                        TABLE 299 PROMOCELL: BUSINESS OVERVIEW 
                        TABLE 300 PROMOCELL: PRODUCTS OFFERED 
             11.2.4 ANTEROGEN CO., LTD. 
                        TABLE 301 ANTEROGEN: BUSINESS OVERVIEW 
                        TABLE 302 ANTEROGEN: PRODUCTS OFFERED 
             11.2.5 CELLGENIX GMBH 
                        TABLE 303 CELLGENIX GMBH: BUSINESS OVERVIEW 
                        TABLE 304 CELLGENIX GMBH: PRODUCTS OFFERED 
*Introduction, Products offered, Recent developments, SWOT analysis, MNM view might not be captured in case of unlisted companies.

12 APPENDIX (Page No. - 289)
     12.1 DISCUSSION GUIDE
     12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     12.3 AVAILABLE CUSTOMIZATIONS
     12.4 RELATED REPORTS
     12.5 AUTHOR DETAILS                        

This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the global stem cell manufacturing market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the stem cell manufacturing market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.

Secondary DATA

The secondary sources referred to for this research study include publications from government and international sources, such as the World Health Organisation (WHO), National Institutes of Health (NIH), International Society for Stem Cell Research (ISSCR), International Stem Cell Forum (ISCF), International Society for Cellular Therapy (ISCT), International Consortium of Stem Cell Networks (ICSCN), EuroStemCell, European Society of Gene and Cell Therapy, German Stem Cell Network, Japan Human Cell Society, Chinese Stem Cell Foundation, Brazilian Association of Cell Therapy, International Journal of Non-Communicable Diseases, European Medicines Agency (EMA), Alliance for Regenerative Medicine (ARM). Secondary sources also include corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global stem cell manufacturing market, which was validated through primary research.

Primary DATA

Extensive primary research was conducted after acquiring basic knowledge about the global stem cell manufacturing market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (personnel from pharmaceutical & biotechnology companies, academic institutes & research centers, and cell banks) and supply-side (C-level and D-level executives, product managers, and marketing and sales managers of key manufacturers, distributors, and channel partners, among others from tier 1 and tier 2 companies engaged in offering product in stem cell manufacturing market) across five major regions—North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Primary research was used in this report to:

  • Validate the market segmentation defined through a product portfolio assessment of the leading players in the stem cell manufacturing market
  • Understand key industry trends and issues defining the strategic growth objectives of market players
  • Gather both demand- and supply-side validation of the key factors affecting the market growth (such as market drivers, restraints, and opportunities)
  • Validate assumptions for the market sizing and forecasting model used for this study
  • Understand the market position of leading players in the stem cell manufacturing market and their market shares/rankings

Stem Cell Manufacturing Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Data Triangulation

After arriving at the overall market size, from the market size estimation process explained above, the stem cell manufacturing market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the stem cell manufacturing market.

Report Objectives

  • To define, describe, and forecast the global stem cell manufacturing market based on product, application, end-user, and region.
  • To provide detailed information on the major factors influencing the market growth (such as drivers, restraints, and opportunities).
  • To strategically analyze micromarkets in terms of individual growth trends, future prospects, and contributions to the overall stem cell manufacturing market.
  • To analyze opportunities in the global market for major stakeholders and provide a detailed competitive landscape for market leaders.
  • To forecast the size of the market segments with respect to five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
  • To profile the key players and comprehensively analyze their market shares and core competencies.
  • To track and analyze competitive developments such as new product launches; acquisitions; expansions; and partnerships, collaborations, and agreements.

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographical Analysis

  • Further breakdown of the Rest of Europe stem cell manufacturing market into respective countries.
  • Further breakdown of the Rest of Asia Pacific stem cell manufacturing market into respective countries.
  • Further breakdown of the Latin American and the MEA stem cell manufacturing market into respective countries.

Company Information

  • Detailed analysis and profiling of additional market players (up to five)
COVID-19

Get in-depth analysis of the COVID-19 impact on the Stem Cell Manufacturing Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Stem Cell Manufacturing Market

Request For Special Pricing
Report Code
BT 6089
Published ON
May, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Stem Cell Manufacturing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved